When administered to individuals who hadn’t been exposed to Covid-19, the drug completely eliminated the risk of severe disease or death, the drugmaker said.
AstraZeneca on Thursday said its Covid-19 prophylaxis drug is 83% effective in reducing the risk of symptomatic Covid-19 infections six months after being given, signaling that the antibody cocktail could be used as an effective means of preventing severe disease in individuals who may not develop a robust immune response to Covid-19 vaccines....
A separate follow-up of the prophylaxis’ phase three trials showed that the drug eliminated the risk of severe Covid-19 and deaths among all recipients over six months after a dose was administered. The drugmaker noted that the trials used a 300-milligram dose of AZD7442 administered into the muscle to individuals who had not been exposed to Covid-19.
The antibody cocktail could prove to be an effective tool to protect people who may not develop a robust immune response after receiving Covid-19 vaccines.AstraZeneca’s chief of research and development, Mene Pangalos, said: “AZD7442 is the only long-acting antibody with Phase III data to demonstrate benefit in both pre-exposure prophylaxis and treatment of Covid-19 with one dose.”700,000. That’s the total number of doses of the antibody drug that AstraZeneca has agreed to supply to the U.S.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Which states have opened COVID-19 vaccine boosters for all?A growing list of states are now moving ahead of federal authorization, recommending booster shots for all residents 18 years or older, six months after receiving their second COVID vaccine dose.
Weiterlesen »
Nurse Salaries Rise as Demand for Their Services Soars During Covid-19 PandemicNurse salaries have gone up by thousands of dollars this year because hospitals and temporary agencies are competing for their work, which has been in increased demand during the pandemic via WSJ
Weiterlesen »
The definition of 'fully vaccinated' is changing to three Covid-19 dosesSome European nations are moving toward mandates on Covid-19 booster shots. By December 15, anyone over the age of 65 will need a third dose to revalidate their vaccination pass in France, President Emmanuel Macron announced last week.
Weiterlesen »
Florida legislature sends DeSantis four bills protecting workers who refuse Covid-19 vaccinationsActing mostly along party lines, the Florida House and Senate passed a package of four bills protecting workers who remain defiant against Covid-19 vaccinations.
Weiterlesen »
Pfizer signs license agreement to allow broader global access to its experimental Covid-19 antiviral pillPfizer said Tuesday it signed a licensing agreement to allow broader global access to its experimental Covid-19 pill.
Weiterlesen »